Hollie C. Foust serves as Executive Vice President, General Counsel, and Corporate Secretary at CONMED Corporation, a global medical technology company specializing in surgical devices and equipment. She joined CONMED in 2011 as Vice President and Associate General Counsel, rising through the ranks due to her strategic legal expertise and leadership. Prior to CONMED, Foust was an associate at the international law firm Alston & Bird LLP, where she honed her skills in complex corporate transactions, mergers and acquisitions, and regulatory compliance. Her transition to in-house counsel marked the beginning of her pivotal role in supporting CONMED's growth amid a dynamic healthcare landscape. In her current position, Foust oversees all legal functions, including corporate governance, risk management, intellectual property, litigation, and securities compliance. As Corporate Secretary, she advises the Board of Directors on governance matters, facilitates board and committee meetings, and ensures adherence to SEC reporting requirements. Under her leadership, CONMED has successfully navigated high-stakes acquisitions, such as the 2022 purchase of In2Bones Global, expanding its orthopedic portfolio, while maintaining robust compliance programs that have strengthened the company's reputation for ethical operations. Foust's achievements include fostering a culture of proactive legal risk mitigation, which has supported CONMED's revenue growth to over $1.2 billion and its expansion into international markets. A graduate of Wake Forest University School of Law (J.D.) and the University of North Carolina at Chapel Hill (B.A.), she is admitted to the New York and Georgia bars and actively engages in industry leadership through organizations like the Association of Corporate Counsel. Her blend of legal acumen and business savvy continues to drive CONMED's strategic objectives.